文献速递脑血管病外科神经重症

阿片类药物使用障碍增加蛛网膜下腔出血后短暂性脑缺血风险

Increased Risk of Transient Cerebral Ischemia After Subarachnoid Hemorrhage in Patients with Premorbid Opioid Use Disorders: A Nationwide Analysis of Outcomes.
PubMed 文献 · World Neurosurg · 2020-05-17

该研究基于2012—2014年美国全国住院患者样本,纳入25,330例接受显微手术夹闭或血管内栓塞的蛛网膜下腔出血患者,其中310例(1.22%)合并阿片类药物使用障碍。多因素回归显示,合并阿片类药物使用障碍者发生短暂性脑缺血的比值显著升高(P=0.044),而其他不良结局未见显著增加。

要点

  • 合并阿片类药物使用障碍的蛛网膜下腔出血患者短暂性脑缺血风险显著升高(P=0.044)。
  • 阿片类药物使用障碍与总并发症、院内死亡、非居家出院等不良结局无显著关联。
  • 建议对蛛网膜下腔出血患者筛查阿片类药物使用障碍以识别需加强监测者。

核心结论

  • 合并阿片类药物使用障碍的急性蛛网膜下腔出血患者住院期间发生伴临床缺损的症状性短暂性脑缺血事件的比值显著更高。

研究设计与样本

  • 基于2012—2014年美国全国住院患者样本(National Inpatient Sample)的回顾性队列分析,使用国际疾病分类编码筛选接受显微手术夹闭或血管内栓塞的蛛网膜下腔出血患者,共纳入25,330例,其中310例(1.22%)合并阿片类药物使用障碍诊断。

主要发现

  • 单因素及多因素回归显示,合并阿片类药物使用障碍者发生短暂性脑缺血的比值较无阿片类药物使用障碍者显著升高(P=0.044)。
  • 阿片类药物使用障碍状态与总并发症、院内死亡、基于经验证的National Inpatient Sample SAH结局指标的预后不良、非居家出院及住院时间延长均无显著关联。

关键数值与推荐

  • 合并阿片类药物使用障碍患者短暂性脑缺血风险升高,P=0.044。
  • 阿片类药物使用障碍在纳入人群中占310/25,330(1.22%)。

临床怎么用

  • 对急性蛛网膜下腔出血患者可筛查阿片类药物使用障碍,以识别可能需要更高水平临床监测以发现出血后短暂性脑缺血事件的个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subarachnoid hemorrhage (SAH) is the most morbid sequela of intracranial aneurysms. Although mortality from SAH has been declining, opioid use in the United States has surged, and neurosurgeons are increasingly tasked with operating on patients with opioid use disorders (OUDs). There is a deficit in the literature regarding how OUDs affect SAH outcomes, particularly transient cerebral ischemic (TCI) events. The objective of this study was to investigate the influence of clinically diagnosed OUDs on the outcomes after acute SAH, with a specific focus on the rate of symptomatic TCI. METHODS: Patients with and without a diagnosed OUD who underwent either microsurgical clipping or endovascular coiling for SAH were queried from the 2012-2014 National Inpatient Sample using International Classification of Disease codes. The primary outcome was the rate of TCI after SAH treatment. RESULTS: A total of 25,330 patients were included, 310 of whom (1.22%) also carried a diagnosis of OUD. Univariate and multivariate regression showed that patients with OUD faced significantly increased odds of TCI (P = 0.044) compared with patients without OUD. OUD status was not associated with increased odds of other adverse outcomes, including overall complication, in-hospital mortality, poor outcome by a validated National Inpatient Sample SAH Outcome Measure, nonhome discharge, or extended hospitalization. CONCLUSIONS: Patients with OUD face significantly higher odds of symptomatic TCI events producing clinical deficits during hospitalization for acute SAH. These findings suggest usefulness in screening patients for OUD to identify individuals who may benefit from a higher level of clinical scrutiny for post-SAH TCI.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Martini ML, Neifert SN, Yaeger KA, et al. Increased Risk of Transient Cerebral Ischemia After Subarachnoid Hemorrhage in Patients with Premorbid Opioid Use Disorders: A Nationwide Analysis of Outcomes. World Neurosurg. 2020. PMID: 32434033. doi:10.1016/j.wneu.2020.05.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。